Title
High incidence of extra-genital gonorrheal and chlamydial infections among high-risk men who have sex with men and transgender women in Peru
Date Issued
01 May 2018
Access level
metadata only access
Resource Type
journal article
Publisher(s)
SAGE Publications Ltd
Abstract
Extra-genital Neisseria gonorrhoeae and Chlamydia trachomatis infections are associated with antimicrobial resistance and HIV acquisition. We analyzed data from a cohort of men who have sex with men (MSM) and transgender women followed quarterly for two years in Peru. Incident cases were defined as positive N. gonorrhoeae or C. trachomatis nucleic acid tests during follow-up. Repeat positive tests were defined as reinfection among those with documented treatment. We used generalized estimating equations to calculate adjusted incidence rate ratios (aIRRs). Of 404 participants, 22% were transgender. Incidence rates of rectal N. gonorrhoeae and C. trachomatis infection were 28.1 and 37.3 cases per 100 person-years, respectively. Incidence rates of pharyngeal N. gonorrhoeae and C. trachomatis infection were 21.3 and 9.6 cases per 100 person-years, respectively. Incident HIV infection was associated with incident rectal (aIRR = 2.43; 95% CI 1.66–3.55) N. gonorrhoeae infection. Identifying as transgender versus cisgender MSM was associated with incident pharyngeal N. gonorrhoeae (aIRR = 1.85; 95% CI 1.12–3.07) infection. The incidence of extra-genital N. gonorrhoeae and C. trachomatis infections was high in our population. The association with incident HIV infection warrants evaluating the impact of rectal N. gonorrhoeae screening and treatment on HIV transmission.
Start page
568
End page
576
Volume
29
Issue
6
Language
English
OCDE Knowledge area
Gastroenterología, Hepatología
Scopus EID
2-s2.0-85045030324
PubMed ID
Source
International Journal of STD and AIDS
ISSN of the container
0956-4624
Sponsor(s)
The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was supported by the United States Funding for this study came from the National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID): 1R01AI099727. The Ethics Committee at Universidad Peruana Cayetano Heredia granted ethical approval for this study with written and informed consent obtained from all patients. For the present analysis, the University of California Los Angeles Institutional Review Board determined that the analysis of deiden-tified data was exempt from ethical review.
Sources of information: Directorio de Producción Científica Scopus